Biotechnology company that researches, develops and commercializes drugs.
Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021; Implementation Delay of 2021 NBPP Rule Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021

Omnibus Appropriations: H.R.133 - Consolidated Appropriations Act, 2021
HCR - Health Issues BUD - Budget/Appropriations
1 - SENATE 1 - SENATE
THE DUBERSTEIN GROUP INC.
325 7th Street NW, Suite 825, Washington, DC, 20004, US
BRIAN GRIFFIN DAVID J SCHIAPPA